Abalos Therapeutics, a German cancer drug developer, has raised 12 million euros in Series A financing. Boehringer Ingelheim Venture Fund and Gruenderfonds Ruhr led the round.
Source: Press Release
Abalos Therapeutics grabs Series A
Nearly there!
We have just sent you an email so you can verify your account. Please check your spam or junk folder just in case it's been delivered there.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: subscriptions@peimedia.com.-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.